Subscribe To Print Edition About The Tribune Code Of Ethics Download App Advertise with us Classifieds

‘30% Covaxin takers reported adverse events’

PTI

Updated At : 12:56 PM May 17, 2024 IST

New Delhi, May 16

Nearly one-third of 926 individuals who received Bharat Biotech’s anti-Covid vaccine Covaxin reported ‘adverse events of special interest,’ or AESI, according to a one-year follow up study conducted by a team of researchers at BHU.

Serious AESI, which included stroke and Guillain-Barre syndrome, were reported in one per cent of individuals, the study conducted by researchers from the Banaras Hindu University (BHU).

Tags :

Bharat

The Tribune, now published from Chandigarh, started publication on February 2, 1881, in Lahore (now in Pakistan). It was started by Sardar Dyal Singh Majithia, a public-spirited philanthropist, and is run by a trust comprising five eminent persons as trustees.

The Tribune, the largest selling English daily in North India, publishes news and views without any bias or prejudice of any kind. Restraint and moderation, rather than agitational language and partisanship, are the hallmarks of the newspaper. It is an independent newspaper in the real sense of the term.

The Tribune has two sister publications, Punjabi Tribune (in Punjabi) and Dainik Tribune (in Hindi).

Remembering Sardar Dyal Singh Majithia

Designed and developed by :

‘30% Covaxin takers reported adverse events’

PTI

Unlock Exclusive Insights with The Tribune Premium